Health
Three common medications lower risk and mortality for lung cancer – Medical Xpress
Combined use of aspirin, statins, and metformin is associated with decreased lung cancer incidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO).
Combined use of aspirin, statins, and metformin is associated with decreased lung cancer incidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO).
All three medications are commonapproximately 35 million people take a statin to control cholesterol; more than 120 million people take metformin to control diabetes; and between 6 and 10 million people take aspirin daily.
The aim of this study was to investigate the associations of aspirin, metformin, and st…
-
General22 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News18 hours agoThe Laundry Lady secures $1M to fuel international expansion
-
Noosa News14 hours agoTruffle growers say rare delicacy is worth its $3,500 per kilo expense
-
General17 hours agoBundaberg bushland gifted for affordable housing amid push to keep green space